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Polyurethane heart valves have been widely studied as possible replacement for mechanical 
and bioprosthetic heart valves. The development of an inexpensive routine production 
technique for manufacturing of polyurethane valves will greatly benefit a very large number 
of patients in developing and emerging countries. A polymer heart valve shows favourable 
physical properties and flow dynamics compared to human heart valves, however, the 
outcome of producing a polymer heart valve with the required flexibility, durability and 
hemodynamic function is often difficult to predict. The design of the mould, the selection of 
the material and the fabrication method used are the key factors that influence the 
achievement of an acceptable heart valve for use in the human body. From their previous 
work on developing a repeatable, semi-automated dip moulding process for producing tri-
leaflet polyurethane heart valves, the authors have shown that the selection of an 
appropriate set of dip moulding process parameters and mould material properties could 
result in achieving polyurethane valve leaflets with the required physical and mechanical 
properties.  
 
This paper reports on the progress made with application of the developed dip moulding 
process to produce polyurethane heart valves suitable for use in human body. The mould, 
frame and sewing ring were manufactured in Ti6Al4V(ELI) by using a Direct Metal Laser 
Sintering (DMLS) process and the valve leaflets were moulded directly onto the sewing ring. 
The heart valve properties obtained are presented and assessed. Conclusions are drawn 
regarding the prospects of these valves surviving the extensive in vitro simulation trials 
required to qualify them for subsequent clinical trials. 
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1. INTRODUCTION:  
The replacement of cardiac valve can either be with biological or artificial valves. The 
biological heart valves experience a short fatigue life and suffer from calcification leading to 
failure. This results in multiple surgeries for their replacement bringing great discomfort in 
the life of the patient [1]. These shortcomings have been overcome by development of 
artificial heart valves, the practice which has been done for a period of more than six 
decades. It has been reported that commercially available mechanical heart valves suffer 
from thromboembolism and require anticoagulation treatment [2][3]. It is not always possible 
to monitor the level of anticoagulation properly since international normalized ratio (INR) 
clinics are not always in close proximity to patients especially in developing and emerging 
countries, and uncontrolled anticoagulation process can lead to internal bleeding within the 
heart[4][5]. 
 
Polyurethane heart valves have been widely studied as possible replacement for mechanical 
and bioprosthetic heart valves [6][7][8]. The development of an inexpensive routine 
production technique for manufacturing of polyurethane valves will greatly benefit a very 
large number of patients in developing and emerging countries. A polymer heart valve shows 
favourable physical properties and flow dynamics compared to human heart valves, however, 
the outcome of producing a polymer heart valve with the required flexibility, durability and 
hemodynamic function is often difficult to predict [3][9][10]. In collaboration with the Robert 
WM Frater Cardiovascular Research Centre, Department of Cardiothoracic Surgery, University 
of the Free State, initial experimental work was done to establish a process and a set of 
process parameters and conditions that would enable repeatable and reliable local 
production of tri-leaflet polyurethane heart valves. This represented only the first phase of 
the development process [11].  
 
Intensive research has been performed in regards with the heart valve design, fabrication 
method and material selection [3][12][13]. Thermoplastic Polyurethane is Food and Drug 
Administration (FDA)-approved family polymer for cardiovascular devices. Thermoplastic 
Polyurethane is a biocompatibility polymer material with relatively good mechanical 
properties and good hydrodynamic function [3][13][14]. A commercial trade mark known as 
PC3595A is one of the series of Polycarbonate urethane which is a family of aliphatic and 
aromatic polycarbonate-based thermoplastic polyurethane. In this study PC3595A granules 
are dissolved through Dimethylacetamide (DMAc) solvent to obtain a solution to be used for 
dip moulding for fabrication of the polyurethane heart valves [11]. 
 
The fabrication methods have an important influence on the physical properties of the 
leaflets, the durability and hemodynamic function of polyurethane valves [3][9]. The human 
heart valve leaflets do not have uniform thickness. For the effectiveness of the hydrodynamic 
function of the valves, they are formed by membranes of various thicknesses along the axis 
of symmetry [15][8]. The dip moulding process was found to produce heart valve leaflets with 
thickness varying uniformly from the top edge (thinner) to the bottom edge where the 
maximum thickness is measured [11]. This is an advantage because the bottom thicker edge 
might provide a sealing function for a trileaflet valve and improve the durability of the valve. 
The research conducted at the University of Strathclyde found that for a good function of the 
heart valve, the leaflet thickness should fall in the 100 to 150 µm thickness range [16].  
 
2. EXPERIMENTAL METHOD 
 
A two-phased development approach was adopted for this project is: 
 
 Phase 1: Establish an experimental set-up to determine dip moulding process 
variables that would result in controllable and reproducible polymer films with the 
potential to be used for heart valves.  
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 Phase 2: The dip moulding parameters developed during Phase 1 will be used with a 
heart valve mould to manufacture heart valves to be used for pulse duplication and, 
fatigue tests. These parameters will also serve as input for computational fluid 
dynamic modelling to identify potential design improvements.  
 
Figure 1 illustrates the two-phased development approach diagrammatically. The FACILITY 
PREPARATION and PROCESS PARAMETERS stages in this diagram represent Phase 1, while the 
MOULD HEART VALVE LEAFLETS and the TESTING HEART VALVES stages represent Phase 2 of 




Figure 1: Representation of the two two-phased development approaches for a 
polyurethane heart valve 
Phase 1 enclosed with (                             ) 
Phase 2 enclosed with (                             ) 
 
 
Phase 1 was completed successfully and the results were published in a previous article [11]. 
Key parameters that have an influence on producing acceptable films were established. These 
parameters include: 
 
 The concentration of the polymer in the polymer-solvent solution,  
 Dipping and withdrawal speed of the mould,  
 Curing temperature,  
 The number of dips. 
 
The focus of the current study was on Phase 2, resulting in prototype polyurethane heart 
valves. 
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2.1 Mould  
 
The mould geometry was prepared through a Direct Metal Laser Sintering (DMLS) process. 
Titanium alloy (Ti6Al4V) was selected due to its high strength and fatigue resistance. Polymer 
valves with an internal diameter of 19 mm were produced through multiple dipping.  
 
2.2 Solution preparation 
 
To manufacture a dip moulded polymer heart valve, a solution of polyurethane (PC3595A 
clear) were dissolved in a solvent (DMAc). The viscosity of the solution depends on the solids 
contents, which can be altered by adding more solvent or polyurethane material to the 
solution until the desired consistency is obtained. A 20% w/w solution was prepared as 
referred to in previous work. 
 
2.3 Dip moulding process 
 
The automated dipping and coating procedure making use of a CNC machine, facilitated a 
smooth and controlled movement of the mould. The mould is lowered at a controlled speed 
into the polymer solution to minimize air bubbles which can result in fatigue failure of the 
finished product and a more even thickness distribution across leaflets. The mould was 
removed from the CNC machine with a thin coating after each dipping, excess polymer 
solution was allowed to drain. The mould was then placed in an air circulating oven at 25°C 
temperature for an hour to remove solvent, dimethylacetamide (DMAc). The leaflet form as 
the solvent evaporates and a thin surface of polymer remains on the mould. This process was 
repeated until the required thickness was obtained. The dip moulded leaflets are released 
from the mould manually.  
 
3. RESULTS AND DISCUSSION 
Different parameters of dip moulding process were evaluated. The Figure 2 shows influence 
of each parameter on producing acceptable polyurethane heart valve. 
 
3.1 Dipping speed 
With three dips, the dipping speed was varied from 2 to 79 mm/min. The highest dipping 
speed was found to display a higher number of air bubbles (Figure 2A) which consequently 
will lead to early failure of the valve. The lowest dipping speed resulted in significant 
reduction of air bubbles (Figure 2C) but did not completely eliminate them.  
 
Figure 2F shows a valve produced from a single dip with no air bubbles entrapped. This 
indicates bubbles are trapped during second and third dips. The CNC machine’s movement, 
used for this review can be as slow as 2 mm/min, with the existence of air bubbles on the 
second and third dip as a results of accumulating a required thickness concludes for another 
parameter to be assessed to eliminate this barrier for a durable valve. 
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Figure 2: Sample of the valves produced with different dip mould parameters 
 
3.2 Preheating temperature, solution concentration and withdrawal speeds 
 At room temperature, PC3595A granules were found partially dissolving with DMAc solvent. 
When the temperature of both mould and polymer solution was raised up to 90ºC, it was 
observed that a homogeneous solution was obtained. However, the preheating process of the 
mould and the solution resulted in about 15% decrease of the thickness of the heart valve 
leaflets in such a way that the newly obtained thicknesses became less than the minimum 
acceptable heart valve leaflet thickness.  
 
To increase the thickness, the withdrawal speed was raised from 20 to 790 mm/min. As this 
effect was also found by other researchers [17][18]. Figure 3 shows a valve produced with a 
higher concentration polymer-solution, when the mould and polymer solution were preheated 
at 90ºC with a single dip at a lower dipping speed and a higher withdrawal speed.  
 
 
Figure 3: Tri-leaflet PU valve produced with dip moulding process without final trimming 
(A) Side view of the valve 
(B) Top view of the valve 
 
The thickness of the obtained heart valve leaflet was measured at different locations of the 




Figure 4: Representation of the tri-leaflet polyurethane valve thickness measurements 
 
The results of the measured thickness are presented in Table 1 
 




1 3 2 4 5 7 6 8 
Thickness 
(µm) 
198±16 173±16 82±9 89±4 91±20 95±23 98±6 85±8 
 
The ideal objective is to obtain the thickness measured at locations 2 and 4 and at locations 
5 and 7 with a difference not more than 10 µm. From Table 1, it can be observed that this 
objective has been achieved. However, the measured thicknesses are less than 100 µm which 




 Figure 5: The SEM micrograph of the leaflet fracture surface 
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Furthermore, the thickness measurement taken at location 1 and 3 on the upper area of the 
tri-leaflet valve is greater than 150 µm, which is the maximum thickness for a good hydraulic 
function of the heart valve leaflets. However, in practice this area is eliminated by trimming, 
from the integral operational part of the heart valve leaflets. The Scanning Electron 
Microscope (SEM) was used to assess the variation of the thickness in vertical direction. The 
minimal thickness was found to be 76 µm at the lowest edge of the heart valve leaflets while 
the maximum value was 249 µm at the upper edge of the heart valve leaflets. This correlates 
with the previous findings where it was mentioned that the thickness varies linearly from 
lower edge with minimum value to the upper edge with the maximum thickness [11].  
 
3.3 Surface topography of polyurethane leaflets 
 
It is desirable that both sides (the side facing the mould and the side facing away from the 
mould) of the leaflets reflect more or less same surface topography. The used mould has six 
vertical flat and three upper curved surfaces (Figure 4). It was observed that for all vertical 
flat and curved surfaces, the leaflet sides facing away the mould displayed more or less same 
surface topography (Figure 6 A & C). The same trend is also observed with the sides facing 
towards the mould (Figure 6 B & D). This showed that the polishing technique of the flat 
vertical and the curved surfaces produced the same quality of surface finish. However, the 
sides facing away the mould (Figure 6 A & C) appeared with smoother surface topography 
than the sides facing towards the mould where uneven surface topography is dominating 
(Figure 6 B & D). 
 
 
Figure 6: SEM micrographs of polyurethane leaflet surface topography for different faces 
(A) Flat surface of the mould facing away from the mould 
(B) Flat surface of the mould facing towards the mould 
(C) Curved surface of the mould facing away from the mould 
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(D) Curved surface of the mould facing towards the mould 
 
The cross-section of the polyurethane leaflet deposited with the dip moulding method is 




Figure 7: SEM micrograph of the fracture surface of a leaflet produced with a single dip 
TPU solution. 
 
One of the first heart valve prototype manufactured was tested on a pulse duplicator 
machine. The machine had the feature to capture an operational video of the valve. Figure 
8 illustrates a tri-leaflet polyurethane valve displaying the functionality of the valve during 
testing inside the pulse duplicator. This is just a visual indication of the valve’s functionality. 
Quantified data on the valve’s performance and lifespan, using the pulse duplicator test, will 
be collected by the Robert WM Frater Cardiovascular Research Centre, Department of 
Cardiothoracic Surgery, University of the Free State. 
 
 
Figure 8: Polyurethane heart valve captured from the fatigue testing video 
(A) Valve fully closed 
(B) Valve fully opened 
 
The team from Robert WM Frater Cardiovascular Research Centre, indicated that from visual 
observation of the valve operational functionality, being able to fully close (Figure 8 A) lead 
to the success of acceptable heart valve for use in the human body. 
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4. CONCLUSION 
 A trileaflet heart valve prototype was successfully produced by dip moulding method 
with promising dynamic and durability functionalities. 
 With a solution concentration varying from 20 to 30%, a single dip could produce a 
trileaflet heart of valve with a thickness varying from 76 to 249 µm in different 
locations of the heart valve leaflet. 
 An excellent surface topography without air bubbles was achieved using a lower 
dipping speed. 
 Future work will focus on quantitative study of pulse duplicator test results as well 
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